Researchers reveal the nature of atherosclerosis from plaque initiation to thrombosis

December 07, 2015

(Boston)--For the first time, researchers can provide early detection of plaques that have a high likelihood of clotting and/or rupture. Boston University School of Medicine (BUSM) scientists have observed the development and evolution of atherosclerotic plaques at the highest risk for thrombosis (clotting) by using non-invasive Magnetic Resonance Imaging (MRI).

The results were reported in the journal Atherosclerosis.

Atherosclerosis is an important contributor to heart attacks and strokes, the leading causes of death in developed nations despite progress in their prevention. Atherosclerosis is a complex disease with many stages, ranging from plaques that can remain clinically silent for decades ("stable") to dangerous ("vulnerable") plaques that in their most highly advanced stage ("highest risk") can suddenly form a blood clot (thrombus) in the vessel, leading to myocardial infarction or stroke.

Researchers at BUSM, under the direction of James A. Hamilton, PhD, Professor of Physiology and Biophysics and Research Professor of medicine at BUSM, pioneered the use of MRI to identify high-risk plaques in a unique experimental model encompassing both atherosclerosis and thrombosis (atherothrombosis). The group established criteria for distinguishing vulnerable and stable plaques from analysis of in vivo (from a living organism) images of mature plaques. The plaques were then tested to determine their stability.

In the new study, images were obtained at monthly intervals to provide information about the pathways of progression (plaque history) of individual plaques in the vessel and to determine whether MRI can discriminate vulnerable and stable plaques at early times.

"Vulnerable plaques and stable plaques showed different physiological progression patterns beginning after one month. Stable plaques exhibited no features of vulnerability at any time, whereas vulnerable plaques showed a progression of vulnerable features, especially in the last month," explained Hamilton, who is the corresponding author.

According to Hamilton, successive MRIs could provide a non-invasive means of identifying plaques that are evolving to become a high risk for rupture. "This work provides us a unique model for evaluating potential therapies after vulnerable plaques are clearly established."
-end-
Funding for this study was provided by NIH P50HL083801 to JAH.

Boston University Medical Center

Related Atherosclerosis Articles from Brightsurf:

How hormone therapy slows progression of atherosclerosis
As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis.

T cells can shift from helping to harming in atherosclerosis
At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place.

New nanoparticle drug combination for atherosclerosis
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Atherosclerosis -- How a microRNA protects vascular integrity
Ludwig-Maximilian-Universitaet (LMU) in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.

Atherosclerosis progresses rapidly in healthy people from the age of 40
A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.

Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing
By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs -- surmounting a major obstacle in nanomedicine.

Bladder drug linked to atherosclerosis in mice
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences (PNAS).

A new therapeutic target for blocking early atherosclerosis in progeria
Researchers at the Centro Nacional de Investigaciones Cardiovasculares and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome.

Protective mechanism against atherosclerosis discovered
Immune cells promoting inflammation play a crucial role in the development of atherosclerosis.

Atherosclerosis: Stopped on time
For the first time, LMU researchers are pointing out the influence of the internal clock on atherosclerosis.

Read More: Atherosclerosis News and Atherosclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.